Nigeria Races to Scale Up Its Production of Medicines

Learn about the complex web of factors impeding Nigeria’s efforts to manufacture quality, affordable pharmaceuticals, including lifesaving malaria medications, and what can be done about it. MSH malaria expert Olugbenga Mokuolu provided comments for the article, emphasizing the need for strong public-private partnerships that identify local production capabilities and guarantee a market for local manufacturers.  

“The idea,” said Mokuolo, “is to increase product availability while keeping costs to consumers down and freeing up governments to deploy limited available resources to support the poorest of the poor through free distribution of malaria commodities.”